Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics (Drugs and the Pharmaceutical Sciences, 136)
0824740785
9780824740788
Description:
This text lists the necessary steps for meeting compliance requirements during the drug development process. It presents comprehensive approaches for validating analytical methods for pharmaceutical applications.
Best prices to buy, sell, or rent ISBN 9780824740788
Related Books
- 1
- 2
- 3
- COMPLIANCE HANDBOOK FOR PHARMACEUTICALS MEDICAL DEVICES AND BIOLOGICSCarmen MedinaISBN-13:9780367247416
- Compliance Handbook for Pharmaceuticals, Medical Devices and BiologicsMEDINAISBN-13:9780824758745
- Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics (Drugs and the Pharmaceutical Sciences)Edition:1ISBN-13:9780367394769
- COMPLIANCE HANDBOOK FOR PHARMACEUTICALS MEDICAL DEVICES AND BIOLOGICSCarmen MedinaISBN-13:9780367247416
- Compliance Handbook for Pharmaceuticals, Medical Devices and BiologicsMEDINAISBN-13:9780824758745
Frequently Asked Questions about Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics (Drugs and the Pharmaceutical Sciences, 136)
The price for the book starts from $101.99 on Amazon and is available from 14 sellers at the moment.
If you’re interested in selling back the Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics (Drugs and the Pharmaceutical Sciences, 136) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics (Drugs and the Pharmaceutical Sciences, 136) book, the best buyback offer comes from and is $ for the book in good condition.
The Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics (Drugs and the Pharmaceutical Sciences, 136) book is in very low demand now as the rank for the book is 3,299,674 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.